Organogenesis Stock Quote ORGO - Stock Price, News, Charts, Message Board, Trades

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Premium

Current Price

2.755

Bid

2.75

Ask

2.76

Volume

301,205

2.655 Day's Range 2.789

1.96 52 Week Range 4.705

Market Cap

364.574M

Previous Close

2.64

Open

2.74

Last Trade

2.755

Last Trade Time

15:25:33

Financial Volume

$ 824,524

VWAP

2.7374

Average Volume (3m)

1,310,161

Shares Outstanding

132,572,465

Dividend Yield

PE Ratio

73.73

Earnings Per Share (EPS)

0.04

Revenue

433.14M

Net Profit

4.95M

Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the advanced wound care, surgical and sports medicine markets. Its product category includes Advanced Wound Care and Surgical and Sports Medicine. The... Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the advanced wound care, surgical and sports medicine markets. Its product category includes Advanced Wound Care and Surgical and Sports Medicine. The company generates maximum revenue from Advanced Wound Care products. Some of its products include PuraPly Antimicrobial, Affinity, NuShield, Apligraf, Dermagraft and others. Show more

Sector

Coml Physical, Biologcl Resh

Industry

Coml Physical, Biologcl Resh

Website

organogenesis.com

Headquarters

Wilmington, Delaware, USA

Founded

1970

Organogenesis Holdings Inc is listed in the Coml Physical, Biologcl Resh sector of the NASDAQ with ticker ORGO. The last closing price for Organogenesis was $2.64. Over the last year, Organogenesis shares have traded in a share price range of $ 1.96 to $ 4.705.

Organogenesis currently has 132,572,465 shares outstanding. The market capitalization of Organogenesis is $364.57 million. Organogenesis has a price to earnings ratio (PE ratio) of 73.73.

Organogenesis Holdings Inc. Reports Fourth Quarter 2023 and Fiscal Year 2023 Financial Results; Introduces Fiscal Year 2024 Guidance

CANTON, Mass., Feb. 29, 2024 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and...

Form 4 - Statement of changes in beneficial ownership of securities

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0.275	11.0887096774	2.48	2.789	2.36	1140957	2.5045138	CS
4	0.025	0.915750915751	2.73	2.83	2.36	1280300	2.57938981	CS
12	-0.025	-0.89928057554	2.78	3.1399	2.165	1310161	2.67714545	CS
26	-1.515	-35.4800936768	4.27	4.705	2.165	975695	2.95840255	CS
52	-0.595	-17.7611940299	3.35	4.705	1.96	938302	2.95027371	CS
156	-14.075	-83.6304218657	16.83	17.5	1.795	989060	5.44733505	CS
260	-4.915	-64.0808344198	7.67	24.3363	1.795	750516	6.94393989	CS

Symbol	Price	Vol.
ASNSActelis Networks Inc	$ 2.4885 (68.14%)	63.9M
LUCYInnovative Eyewear Inc	$ 0.5082 (54.00%)	351.44M
COSMCosmos Health Inc	$ 1.0313 (51.89%)	78.58M
NNENano Nuclear Energy Inc	$ 23.135 (42.63%)	8.29M
NBSTWNewbury Street Acquisition Corporation	$ 0.0613 (39.32%)	19.62k
BTOGBit Origin Ltd	$ 2.8199 (-46.99%)	3.19M
SAVACassava Sciences Inc	$ 10.10 (-46.70%)	12.09M
CINGCingulate Inc	$ 0.3199 (-45.22%)	2.19M
ACCDAccolade Inc	$ 3.625 (-43.27%)	12.55M
NXLNexalin Technologies Inc	$ 1.75 (-40.88%)	4.1M
LUCYInnovative Eyewear Inc	$ 0.5082 (54.00%)	351.44M
NVDANVIDIA Corporation	$ 124.145 (0.13%)	229M
FFIEFaraday Future Intelligent Electric Inc	$ 0.5356 (-10.73%)	182.54M
SQQQProShares UltraPro Short QQQ	$ 8.19 (0.74%)	131.29M
TSLATesla Inc	$ 196.21 (-0.61%)	78.79M

Symbol

Price

Vol.